• Aucun résultat trouvé

latanoprost; 0,05 mg/ml; eye drops, solution

N/A
N/A
Info
Télécharger
Protected

Academic year: 2022

Partager "latanoprost; 0,05 mg/ml; eye drops, solution "

Copied!
1
0
0

Chargement.... (Voir le texte intégral maintenant)

Texte intégral

(1)

Annex 5.19 – List of proposed (invented) names and marketing authorisation holders in the concerned member states

DK/H/2754/001/DC

latanoprost; 0,05 mg/ml; eye drops, solution

Member State Product name MAH

DK Vizilatan

PharmaSwiss Česká republika, s.r.o., Jankovcova 1569/2c, Prague 7,

Czech Republic

BG Визилат 0,05 mg/ml капки за очи, разтвор

PharmaSwiss Česká republika, s.r.o., Jankovcova 1569/2c, Prague 7,

Czech Republic

CZ Vizilatan

PharmaSwiss Česká republika, s.r.o., Jankovcova 1569/2c, Prague 7,

Czech Republic

GR Visiolatan

PharmaSwiss Česká republika, s.r.o., Jankovcova 1569/2c, Prague 7,

Czech Republic

FR Vizilatan 0,05 mg/ml,

collyre en solution

Laboratoire CHAUVIN 416 rue Samuel Morse CS 99535 MONTPELLIER Cedex 2, 34961,

France

HR Vizilatan

PharmaSwiss Česká republika, s.r.o., Jankovcova 1569/2c, Prague 7,

Czech Republic

HU Vizilatan 0,05 mg/ml oldatos szemcsepp

PharmaSwiss Česká republika, s.r.o., Jankovcova 1569/2c, Prague 7,

Czech Republic

NL Vizilatan 0,05 mg/ml oogdruppels, oplossing

Bausch & Lomb Pharma Bvd Lambermontlaan 430 Brussel,

B-1030, Belgium

PL Vizilatan

PharmaSwiss Česká republika, s.r.o., Jankovcova 1569/2c, Prague 7,

Czech Republic

SK Vizilatan 0,05 mg/ml

PharmaSwiss Česká republika, s.r.o., Jankovcova 1569/2c, Prague 7,

Czech Republic

Références

Télécharger maintenant ( PDF - 1 Page - 141.31 KB )

Documents relatifs

Travoprost, Preservative Free eye drops, solution 40 µg/ml

oogdruppels, oplossing zonder bewaarmiddel Travoprost Bausch & Lomb 40 µg/ml collyre en solution sans conservateur. Travoprost Bausch & Lomb 40 µg/ml Augentropfen

Package leaflet: Information for the user [Invented name] 40 micrograms/mL+ 5 mg/mL eye drops, solution

Tell your doctor before you have an operation that you are using [Invented name] as timolol may change effects of some medicines used during anaesthesia.. [Invented name] may

NAME OF THE MEDICINAL PRODUCT [Invented name] 40 micrograms/mL + 5 mg/mL eye drops, solution travoprost/timolol 2

SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN.. Keep out of the sight and reach

[TRAVOPROST + TIMOLOL] 40 MCG/ML + 5 MG/ML, PRESERVATIVE-FREE EYE DROPS, SOLUTION RISK MANAGEMENT PLAN

Five clinical studies were conducted for DuoTrav 40 micrograms/mL + 5 mg/mL eye drops, solution (Alcon Laboratories) to support the efficacy and safety of the

NAME OF THE MEDICINAL PRODUCT [Invented name] 50 micrograms/mL eye drops, solution Latanoprost 2

Excipients: Macrogolglycerol hydroxystearate 40, sodium chloride, disodium edetate, sodium dihydrogen phosphate dihydrate, anhydrous disodium phosphate, hydrochloric acid or/and

RISK MANAGEMENT PLAN [LATANOPROST] 50 MCG/ML PRESERVATIVE FREE EYE DROPS, SOLUTION

[LATANOPROST] 50 mcg/ml preservative free eye drops, solution is indicated for thereduction of elevated intraocular pressure in patients with open angle glaucoma and

Decentralized Procedure DK/H/2754/001/DC UUID: 4dfb4ba4-f07d-4e39-8615-5201078dfe31 Vizilatan 0,05 mg/ml; eye drops, solution

[r]

NAME OF THE MEDICINAL PRODUCT [Invented name] 0.3 mg/mL + 5 mg/mL eye drops, solution bimatoprost/timolol 2

SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN.. Keep out of the sight and reach